{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:25:13Z","timestamp":1794561913986,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymgme.2026.110162","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T22:57:36Z","timestamp":1779058656000},"page":"110162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resources and care structures for management of urea cycle disorders in Japan and the United States: A system-level comparison"],"prefix":"10.1016","volume":"148","author":[{"given":"Yoko","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"MacLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konomi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas Ah.","family":"Mew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiko","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110162_bb0005","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jimd.12100","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision","volume":"42","author":"Haberle","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110162_bb0010","series-title":"GeneReviews((R))","article-title":"Urea cycle disorders overview","author":"Simpson","year":"1993"},{"key":"10.1016\/j.ymgme.2026.110162_bb0015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10545-011-9427-0","article-title":"Long-term outcome and intervention of urea cycle disorders in Japan","volume":"35","author":"Kido","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110162_bb0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2013.07.008","article-title":"The incidence of urea cycle disorders","volume":"110","author":"Summar","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2026.110162_bb0025","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.ymgme.2010.02.019","article-title":"New insights in nutritional management and amino acid supplementation in urea cycle disorders","volume":"100","author":"Scaglia","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110162_bb0030","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s10545-007-0718-4","article-title":"Nutritional management of patients with urea cycle disorders","volume":"30","author":"Singh","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110162_bb0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ymgme.2008.05.004","article-title":"Cross-sectional multicenter study of patients with urea cycle disorders in the United States","volume":"94","author":"Tuchman","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110162_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-7-32","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders","volume":"7","author":"Haberle","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110162_bb0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/17446651.2014.945908","article-title":"Glycerol phenylbutyrate for the chronic management of urea cycle disorders","volume":"9","author":"Oishi","year":"2014","journal-title":"Expert. Rev. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2026.110162_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ymgme.2014.02.007","article-title":"Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes","volume":"112","author":"Berry","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110162_bb0055","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymgme.2019.07.004","article-title":"Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients","volume":"127","author":"Diaz","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110162_bb0060","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1001\/jama.2024.17275","article-title":"Strategies to help patients navigate high prescription drug costs","volume":"332","author":"Lalani","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2026.110162_bb0065","series-title":"Treatment Choice in Urea Cycle Disorders: How Healthcare Access Contributes to the Decision to Continue Medical Management or Pursue Liver Transplant","author":"Gerstein","year":"2019"},{"key":"10.1016\/j.ymgme.2026.110162_bb0070","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/jimd.12384","article-title":"Long-term outcome of urea cycle disorders: report from a nationwide study in Japan","volume":"44","author":"Kido","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110162_bb0075","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/ped.13163","article-title":"Citrulline for urea cycle disorders in Japan","volume":"59","author":"Tanaka","year":"2017","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ymgme.2026.110162_bb0080","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/17446651.2016.1239526","article-title":"Efficacy of N-carbamoyl-L-glutamic acid for the treatment of inherited metabolic disorders","volume":"11","author":"Chapel-Crespo","year":"2016","journal-title":"Expert. Rev. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2026.110162_bb0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1586\/eem.12.17","article-title":"Carglumic acid for the treatment of N-acetylglutamate synthase deficiency and acute hyperammonemia","volume":"7","author":"Haberle","year":"2012","journal-title":"Expert. Rev. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2026.110162_bb0090","series-title":"Urea Cycle Disorders, Newborn Mass Screening Disease Practice Guideline 2019 [in Japanese]","first-page":"67","author":"Japanese Society for Inherited Metabolic Diseases","year":"2019"},{"key":"10.1016\/j.ymgme.2026.110162_bb0095","first-page":"76","article-title":"Milk list for special formulas (in Japanese)","volume":"58","author":"Aiikukai","year":"2023","journal-title":"Boshi Aiikukai"},{"key":"10.1016\/j.ymgme.2026.110162_bb0100","author":"Genetic Metabolic Dietitians International"},{"key":"10.1016\/j.ymgme.2026.110162_bb0105","author":"Nutricia North America, Urea Cycle Disorders (UCD)"},{"key":"10.1016\/j.ymgme.2026.110162_bb0110","author":"National Organization for Rare Disorders"},{"key":"10.1016\/j.ymgme.2026.110162_bb0115","series-title":"Report on the Quality and Stable Supply of Special Formulas for Inborn Errors of Metabolism for FY2023 Health and Labour Sciences Research Grants: Rare and Intractable Diseases Program (in Japanese)","author":"Oishi","year":"2024"},{"key":"10.1016\/j.ymgme.2026.110162_bb0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5582\/irdr.2025.01067","article-title":"Challenges in Japan\u2019s dual systems of support for pediatric and adult intractable diseases","volume":"14","author":"Karako","year":"2025","journal-title":"Intract. Rare Dis. Res."},{"key":"10.1016\/j.ymgme.2026.110162_bb0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5582\/irdr.2021.01145","article-title":"Current status of specific pediatric chronic diseases in Japan: national measures, disease types, treatment availability, copayment assistance, and research","volume":"10","author":"Sawakami","year":"2021","journal-title":"Intract. Rare Dis. Res."},{"key":"10.1016\/j.ymgme.2026.110162_bb0130","article-title":"Current status of surviving patients with arginase 1 deficiency in Japan","volume":"29","author":"Kido","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110162_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/nu16010013","article-title":"Long-term management of patients with mild urea cycle disorders identified through the Newborn screening: An expert opinion for clinical practice","volume":"16","author":"Burlina","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2026.110162_bb0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpeds.2017.05.048","article-title":"The relationship between dietary intake, growth, and body composition in inborn errors of intermediary protein metabolism","volume":"188","author":"Evans","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110162_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/nu12113331","article-title":"Nutrient intake and nutritional status in adult patients with inherited metabolic diseases treated with low-protein diets: a review on urea cycle disorders and branched chain organic acidemias","volume":"12","author":"Francini-Pesenti","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2026.110162_bb0150","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/ped.12439","article-title":"Diagnosis and treatment of urea cycle disorder in Japan","volume":"56","author":"Nakamura","year":"2014","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ymgme.2026.110162_bb0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2014.08.001","article-title":"A longitudinal study of urea cycle disorders","volume":"113","author":"Batshaw","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110162_bb0160","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/gim.2013.46","article-title":"Insurance coverage of medical foods for treatment of inherited metabolic disorders","volume":"15","author":"Berry","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110162_bb0165","series-title":"Overview of Medical Service Regime in Japan","author":"Ministry of Health Labour and Welfare Japan","year":"2024"},{"key":"10.1016\/j.ymgme.2026.110162_bb0170","article-title":"Compensation for metabolic dietitians practicing in the United States: 2023 Genetic Metabolic Dietitians International professional status survey","volume":"41","author":"Viau","year":"2024","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110162_bb0175","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1097\/GIM.0b013e3181fe5d23","article-title":"The inborn errors of metabolism information system: a project of the Region 4 Genetics Collaborative Priority 2 Workgroup","volume":"12","author":"Berry","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2026.110162_bb0180","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/gim.2016.57","article-title":"Inborn Errors of Metabolism Collaborative: large-scale collection of data on long-term follow-up for newborn-screened conditions","volume":"18","author":"Berry","year":"2016","journal-title":"Genet. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2026.110162_bb0185","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.ymgme.2010.01.014","article-title":"Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium","volume":"100","author":"Seminara","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110162_bb0190","series-title":"Overview of the FY2022 Revision of Medical Service Fees (Nutrition-Related Provisions) (in Japanese)","author":"Ministry of Health Labour and Welfare Japan","year":"2022"},{"key":"10.1016\/j.ymgme.2026.110162_bb0195","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/cpt.3553","article-title":"Evolving research and development landscape for rare diseases: growing concerns over orphan drug lag in Japan","volume":"117","author":"Enya","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ymgme.2026.110162_bb0200","doi-asserted-by":"crossref","first-page":"8","DOI":"10.35772\/ghm.2026.01011","article-title":"Japan\u2019s high-quality healthcare system despite physician shortages: exploring the paradox and pathways toward sustainable healthcare","volume":"8","author":"Uenishi","year":"2026","journal-title":"Glob. Health Med."},{"key":"10.1016\/j.ymgme.2026.110162_bb0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1248\/yakushi.25-00140-1","article-title":"Increasing orphan drug loss in Japan: trends and R&D strategy for rare diseases","volume":"146","author":"Enya","year":"2026","journal-title":"Yakugaku Zasshi"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:23:21Z","timestamp":1794558201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226004452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1096719226004452"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110162","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resources and care structures for management of urea cycle disorders in Japan and the United States: A system-level comparison","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110162"}}